Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
0R
0RKL.LSE
0R
0RKL.LSE
0RKL.LSE
News
·
Nomination Committee of XVIVO Perfusion AB (publ)
Mkt Cap
N/A
Volume
N/A
Next Earnings
N/A
Chart
Earnings
News
About
Insider
Filings
Nomination Committee of XVIVO Perfusion AB (publ)
GOTHENBURG, SE / ACCESS Newswire / September 30, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The following members have been appointed to XVIVO Perfusion's nomination committee for the 2027 annual general meeting: Henrik Blomquist, appointed by Bure Equity AB Thoma…
finance.yahoo.com · Sep 30, 2026
XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System
CAUTION-Investigational device in the US. Limited by Federal (United States) law to investigational use. The safety and effectiveness of this device have not been established. The XVIVO heart technology is not commercially available in the US. GOTHENBURG, SE / ACCESS Newswire / S…
finance.yahoo.com · Sep 28, 2026
XVIVO Presents Report on Operations 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / January 25, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Fourth quarter 2023 (October 1 - December 31) • Net sales amounted to SEK 155.7 million (131.5), corresponding to an increase of 18 percent in SEK and 16 percent in local curren…
finance.yahoo.com · Jan 25, 2024
Extended Perfusion Time of Livers Can Streamline Planning and Logistics - Enabling More Liver Transplants to be Performed During Daytime
GOTHENBURG, SE / ACCESSWIRE / January 24, 2024 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL)(FRA:3XV) In a recently published [1] clinical trial conducted by the UMCG in Groningen, the Netherlands, XVIVO's Liver Assist has demonstrated its potential to reshape liver transplant logi…
finance.yahoo.com · Jan 24, 2024
Conference Call on Report on Operations 2023
GOTHENBURG, SE / ACCESSWIRE / January 12, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Invitation to attend XVIVO's conference call regarding the presentation of the Report on Operations 2023. The presentation will be held in English. Time: Thursday, January 25 at 2.0…
finance.yahoo.com · Jan 12, 2024
XVIVO Reaches Milestone in Italy: 1,200 Lifesaving Perfusions Performed with Liver Assist
GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) In 2014, XVIVO introduced an innovative liver technology to the Italian market, designed for oxygenated perfusion prior to transplantation. Today, we are proud to announce that…
finance.yahoo.com · Dec 22, 2023
XVIVO Announces a Write-Down Related to PrimECC of SEK 17 Million Not Affecting Cashflow or EBITDA
GOTHENBURG, SWEDEN / ACCESSWIRE / December 14, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) As communicated on July 12, 2023, XVIVO has decided to close its´ PrimECC study for further patient inclusions and to evaluate potential strategic opportunities. The decision h…
finance.yahoo.com · Dec 14, 2023
Results from a Australian/New Zealand study using XVIVO’s Heart Technology Published
GOTHENBURG, SE / ACCESSWIRE / November 3, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The results of the clinical trial conducted in Australia and New Zealand on XVIVO's heart technology were earlier this week published in the prestigious scientific journal, The Jour…
finance.yahoo.com · Nov 3, 2023
Interim Report January-September 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / October 24, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Third quarter 2023 (July 1 - September 30) • Net sales amounted to SEK 146.6 million (96.8), corresponding to an increase of 51 percent in SEK and 42 percent in local currencies…
finance.yahoo.com · Oct 24, 2023
Leading Academic Medical Center Performs First Heart Transplant in the U.S. Utilizing NIHP Technology as Part of XVIVO's PRESERVE Clinical Trial
GOTHENBURG, SWEDEN / ACCESSWIRE / October 23, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) On October 14, 2023 Duke University Hospital in Durham, N.C., performed the first heart transplant in the U.S. using XVIVO's Non-Ischemic Heart Preservation (NIHP) device and so…
finance.yahoo.com · Oct 23, 2023
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
0R
0RKL.LSE
0RKL.LSE
Buy
Sell
Market
Limit
Soon
0RKL.LSE
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any 0RKL.LSE yet.
Related Tickers
Earnings